[Fibrinolytics. 46].
D003374:Coumarins / Q000627:therapeutic use; D001728:Dicumarol / Q000627:therapeutic use; D004617:Embolism; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006496:Heparinoids / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000188:drug therapy; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use; D013300:Streptokinase / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy*
D003374:Coumarins; D005343:Fibrinolytic Agents; D006496:Heparinoids; D001728:Dicumarol; D006493:Heparin; D013299:Streptodornase and Streptokinase; D013300:Streptokinase
Fibrinolytika. 46.